Sym Financial Corp Eli Lilly & CO Transaction History

Sym Financial Corp

$745 Million
Q3 2024

A detailed history of Sym Financial Corp transactions in Eli Lilly & CO stock. As of the latest transaction made, Sym Financial Corp holds 5,795 shares of LLY stock, worth $4.48 Million. This represents 0.69% of its overall portfolio holdings.

Number of Shares

5,795

Previous 5,667 2.26%

Holding current value

$4.48 Million

Previous $5.13 Million 0.08%

% of portfolio

0.69%

Previous 0.82%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$772.14 - $960.02 $98,833 - $122,882	128 Added 2.26%	5,795 $5.13 Million
Q2 2024 Aug 08, 2024	BUY	$724.87 - $909.04 $296,471 - $371,797	409 Added 7.78%	5,667 $5.13 Million
Q1 2024 May 06, 2024	SELL	$592.2 - $792.28 $522,912 - $699,583	-883 Reduced 14.38%	5,258 $4.09 Million
Q4 2023 Feb 06, 2024	BUY	$525.19 - $619.13 $191,169 - $225,363	364 Added 6.3%	6,141 $3.58 Million
Q3 2023 Oct 27, 2023	BUY	$434.7 - $599.3 $76,072 - $104,877	175 Added 3.12%	5,777 $3.1 Million
Q2 2023 Aug 02, 2023	SELL	$350.74 - $468.98 $77,513 - $103,644	-221 Reduced 3.8%	5,602 $2.63 Million
Q4 2022 Jan 19, 2023	BUY	$321.55 - $374.67 $4,501 - $5,245	14 Added 0.24%	5,823 $0
Q3 2022 Oct 28, 2022	SELL	$296.48 - $337.87 $70,562 - $80,413	-238 Reduced 3.94%	5,809 $1.88 Million
Q2 2022 Jul 19, 2022	SELL	$278.73 - $327.27 $192,602 - $226,143	-691 Reduced 10.26%	6,047 $1.96 Million
Q1 2022 Apr 22, 2022	SELL	$234.69 - $291.66 $78,386 - $97,414	-334 Reduced 4.72%	6,738 $1.93 Million
Q4 2021 Feb 03, 2022	SELL	$224.85 - $279.04 $68,804 - $85,386	-306 Reduced 4.15%	7,072 $1.95 Million
Q3 2021 Oct 15, 2021	BUY	$221.6 - $272.71 $80,662 - $99,266	364 Added 5.19%	7,378 $1.71 Million
Q2 2021 Jul 20, 2021	BUY	$180.55 - $233.54 $221,173 - $286,086	1,225 Added 21.16%	7,014 $1.61 Million
Q1 2021 Apr 19, 2021	BUY	$164.32 - $212.72 $164 - $212	1 Added 0.02%	5,789 $1.08 Million
Q4 2020 Jan 26, 2021	SELL	$130.46 - $172.63 $8,349 - $11,048	-64 Reduced 1.09%	5,788 $977,000
Q3 2020 Oct 13, 2020	BUY	$146.22 - $169.13 $1,169 - $1,353	8 Added 0.14%	5,852 $866,000
Q2 2020 Jul 27, 2020	SELL	$136.42 - $164.18 $17,734 - $21,343	-130 Reduced 2.18%	5,844 $959,000
Q1 2020 Apr 28, 2020	BUY	$119.05 - $147.35 $158,931 - $196,712	1,335 Added 28.78%	5,974 $829,000
Q4 2019 Feb 11, 2020	SELL	$106.92 - $132.43 $101,467 - $125,676	-949 Reduced 16.98%	4,639 $610,000
Q3 2019 Nov 04, 2019	SELL	$106.79 - $116.16 $453,750 - $493,563	-4,249 Reduced 43.19%	5,588 $625,000
Q2 2019 Jul 29, 2019	SELL	$110.79 - $129.32 $49,190 - $57,418	-444 Reduced 4.32%	9,837 $1.09 Million
Q1 2019 May 14, 2019	SELL	$111.31 - $131.02 $48,865 - $57,517	-439 Reduced 4.1%	10,281 $1.33 Million
Q4 2018 Feb 13, 2019	BUY	$105.9 - $118.64 $46,701 - $52,320	441 Added 4.29%	10,720 $1.24 Million
Q3 2018 Nov 14, 2018	BUY	$85.86 - $107.31 $85 - $107	1 Added 0.01%	10,279 $1.1 Million
Q2 2018 Aug 13, 2018	SELL	$75.7 - $86.88 $30,961 - $35,533	-409 Reduced 3.83%	10,278 $877,000
Q1 2018 May 15, 2018	SELL	$74.21 - $87.6 $22,930 - $27,068	-309 Reduced 2.81%	10,687 $827,000
Q4 2017 Feb 14, 2018	BUY	$81.94 - $87.89 $901,012 - $966,438	10,996	10,996 $929,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $735B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sym Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Sym Financial Corp with notifications on news.

Account

Sym Financial Corp Eli Lilly & CO Transaction History